冠動脈ステント市場：タイプ別（薬剤溶出ステント、ベアメタル冠動脈ステント、生体吸収性ステント）、生体材料別（金属生体材料、高分子生体材料、天然生体材料）、エンドユーザー別（病院、外来手術センター、その他）。世界の機会分析および産業予測、2020-2030年

Coronary Stents Market By Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), By Biomaterial (Metallic biomaterials, Polymers biomaterials, Natural biomaterials), By End User (Hospitals, Ambulatory Surgical Centers, Other): Global Opportunity Analysis and Industry Forecast, 2020-2030

冠動脈ステントの世界市場は、2020年には88億1490万ドル、2030年には154億2106万ドルに達すると予測され、2021年から2030年までのCAGRは6.0%を記録しています。冠動脈ステントは、拡張可能な小型チューブであり... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,769 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	236	英語

サマリー

冠動脈ステントの世界市場は、2020年には88億1490万ドル、2030年には154億2106万ドルに達すると予測され、2021年から2030年までのCAGRは6.0%を記録しています。
冠動脈ステントは、拡張可能な小型チューブであり、狭窄または閉塞した冠動脈の治療や胸痛（狭心症）の軽減に使用されます。冠動脈疾患（CAD）患者は、これらのステントを使用して治療されます。これらのステントは心臓ステントとも呼ばれ、金属製のメッシュで構成されています。これらの冠動脈ステントは、経皮的冠動脈インターベンション（PCI）中に狭窄した冠動脈に留置されます。
冠動脈ステント市場の成長を促進する要因は、CADの発生率の増加、冠動脈ステントの技術革新の上昇、およびステントによる臨床転帰の改善のサージが含まれています。
また、慢性疾患や生活習慣病、特に糖尿病や肥満の発生率の上昇、保険や診療報酬のシナリオの改善が、世界の冠動脈ステント市場の成長を補完しています。
逆に、冠動脈疾患治療のための代替方法の利用可能性と冠動脈ステントに関連する治療費の高騰は、予測期間中の市場の成長を阻害します。しかし、発展途上国における冠動脈ステントの採用の増加は、予測期間中に市場に有利な成長機会を提供することが期待されます。
冠動脈ステントの世界市場は、製品、生体材料、エンドユーザー、地域に基づいて区分されます。製品別では、薬剤溶出性ステント、ベアメタルステント、生体吸収性血管ステントに分類されます。バイオマテリアルにより、金属系、高分子系、天然バイオマテリアルに分類されます。エンドユーザー別では、病院、外来手術センター、その他に分類されます。地域別では、北米、ヨーロッパ、アジア太平洋、LAMEAで分析されています。
本レポートで紹介する主な市場参加者は、Abbott Laboratories、B. Braun Melsungen AG、Boston Scientific Corporation、Becton Dickinson and Company、Microport Scientific Corporation、Terumo Corporation、Medtronic plc.、Biotronik SE & Co.KG、Biosensors International Group, Ltd.、Elixir Medical Corporation。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CORONARY STENTS MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Drug-eluting Stents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Bare-metal Coronary Stents
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Bioabsorbable Stents
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: CORONARY STENTS MARKET, BY BIOMATERIAL
5.1 Overview
5.1.1 Market size and forecast
5.2 Metallic biomaterials
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Polymers biomaterials
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Natural biomaterials
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: CORONARY STENTS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Other
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: CORONARY STENTS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Biomaterial
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Biomaterial
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Biomaterial
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Biomaterial
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Biomaterial
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Biomaterial
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Biomaterial
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Biomaterial
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Biomaterial
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Biomaterial
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of LAMEA
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Biomaterial
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Biomaterial
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Biomaterial
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Biomaterial
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Biomaterial
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Biomaterial
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Biomaterial
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of LAMEA
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Biomaterial
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Biomaterial
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Biomaterial
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Biomaterial
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Biomaterial
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Biomaterial
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 B. Braun Melsungen AG
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Biotronik Se & Co. KG
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Boston Scientific Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Becton, Dickinson and Company
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Elixir Medical Corporation
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Medtronic PLC.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Microport Scientific Corporation
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Biosensors International Group
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Terumo Corporation
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 2. CORONARY STENTS MARKET REVENUE, FOR DRUG-ELUTING STENTS, BY REGION , 2020-2030,($MILLION)
TABLE 3. CORONARY STENTS MARKET DRUG-ELUTING STENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. CORONARY STENTS MARKET REVENUE, FOR BARE-METAL CORONARY STENTS, BY REGION , 2020-2030,($MILLION)
TABLE 5. CORONARY STENTS MARKET BARE-METAL CORONARY STENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. CORONARY STENTS MARKET REVENUE, FOR BIOABSORBABLE STENTS, BY REGION , 2020-2030,($MILLION)
TABLE 7. CORONARY STENTS MARKET BIOABSORBABLE STENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
TABLE 9. CORONARY STENTS MARKET REVENUE, FOR METALLIC BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
TABLE 10. CORONARY STENTS MARKET METALLIC BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. CORONARY STENTS MARKET REVENUE, FOR POLYMERS BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
TABLE 12. CORONARY STENTS MARKET POLYMERS BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. CORONARY STENTS MARKET REVENUE, FOR NATURAL BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
TABLE 14. CORONARY STENTS MARKET NATURAL BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. GLOBAL CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 16. CORONARY STENTS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
TABLE 17. CORONARY STENTS MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. CORONARY STENTS MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2020-2030,($MILLION)
TABLE 19. CORONARY STENTS MARKET AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. CORONARY STENTS MARKET REVENUE, FOR OTHER, BY REGION , 2020-2030,($MILLION)
TABLE 21. CORONARY STENTS MARKET OTHER BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. CORONARY STENTS MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 23. NORTH AMERICA CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 24. NORTH AMERICA CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
TABLE 25. NORTH AMERICA CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. U.S. CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 28. U.S. CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 29. U.S. CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 30. CANADA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 31. CANADA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 32. CANADA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 33. MEXICO CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 34. MEXICO CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 35. MEXICO CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 36. EUROPE CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 37. EUROPE CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
TABLE 38. EUROPE CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 39. EUROPE CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 40. GERMANY CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 41. GERMANY CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 42. GERMANY CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 43. FRANCE CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 44. FRANCE CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 45. FRANCE CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 46. U.K. CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 47. U.K. CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 48. U.K. CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 49. ITALY CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 50. ITALY CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 51. ITALY CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 52. SPAIN CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 53. SPAIN CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 54. SPAIN CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 55. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 56. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 57. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 58. ASIA-PACIFIC CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 59. ASIA-PACIFIC CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
TABLE 60. ASIA-PACIFIC CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 61. ASIA-PACIFIC CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 62. CHINA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 63. CHINA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 64. CHINA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 65. JAPAN CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 66. JAPAN CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 67. JAPAN CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 68. INDIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 69. INDIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 70. INDIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 71. AUSTRALIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 72. AUSTRALIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 73. AUSTRALIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 74. SOUTH KOREA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 75. SOUTH KOREA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 76. SOUTH KOREA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 77. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 78. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 79. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 80. LAMEA CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 81. LAMEA CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
TABLE 82. LAMEA CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 83. LAMEA CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 84. BRAZIL CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 85. BRAZIL CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 86. BRAZIL CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 87. SAUDI ARABIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 88. SAUDI ARABIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 89. SAUDI ARABIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 90. SOUTH AFRICA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 91. SOUTH AFRICA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 92. SOUTH AFRICA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 93. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
TABLE 94. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
TABLE 95. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
TABLE 96.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 97.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 98.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 99.ABBOTT LABORATORIES: NET SALES,
TABLE 100.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 101.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 102.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 103.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 104.B. BRAUN MELSUNGEN AG: NET SALES,
TABLE 105.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 106.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 107.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
TABLE 108.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 109.BIOTRONIK SE & CO. KG: NET SALES,
TABLE 110.BIOTRONIK SE & CO. KG: KEY STRATERGIES
TABLE 111.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 112.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 113.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 114.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 115.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 116.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 117.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 118.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 119.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 120.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 121.ELIXIR MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 122.ELIXIR MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 123.ELIXIR MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 124.ELIXIR MEDICAL CORPORATION: NET SALES,
TABLE 125.ELIXIR MEDICAL CORPORATION: KEY STRATERGIES
TABLE 126.MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 127.MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 128.MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 129.MEDTRONIC PLC.: NET SALES,
TABLE 130.MEDTRONIC PLC.: KEY STRATERGIES
TABLE 131.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 132.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 133.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 134.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
TABLE 135.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 136.BIOSENSORS INTERNATIONAL GROUP: COMPANY SNAPSHOT
TABLE 137.BIOSENSORS INTERNATIONAL GROUP: OPERATING SEGMENTS
TABLE 138.BIOSENSORS INTERNATIONAL GROUP: PRODUCT PORTFOLIO
TABLE 139.BIOSENSORS INTERNATIONAL GROUP: NET SALES,
TABLE 140.BIOSENSORS INTERNATIONAL GROUP: KEY STRATERGIES
TABLE 141.TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 142.TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 143.TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 144.TERUMO CORPORATION: NET SALES,
TABLE 145.TERUMO CORPORATION: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.CORONARY STENTS MARKET SEGMENTATION
FIGURE 2.CORONARY STENTS MARKET,2020-2030
FIGURE 3.CORONARY STENTS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CORONARY STENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.CORONARY STENTS MARKET,BY TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DRUG-ELUTING STENTS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BARE-METAL CORONARY STENTS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BIOABSORBABLE STENTS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 15.CORONARY STENTS MARKET,BY BIOMATERIAL,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF METALLIC BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF POLYMERS BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NATURAL BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 19.CORONARY STENTS MARKET,BY END USER,2020(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS CORONARY STENTS MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHER CORONARY STENTS MARKET,2020-2030(%)
FIGURE 23.CORONARY STENTS MARKET BY REGION,2020
FIGURE 24.U.S. CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 25.CANADA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 26.MEXICO CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 27.GERMANY CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 28.FRANCE CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 29.U.K. CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 30.ITALY CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 31.SPAIN CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 32.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 33.CHINA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 34.JAPAN CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 35.INDIA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 36.AUSTRALIA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 37.SOUTH KOREA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 38.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 39.BRAZIL CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 40.SAUDI ARABIA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 41.SOUTH AFRICA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 42.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47.COMPETITIVE DASHBOARD
FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 50.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
FIGURE 51.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
FIGURE 52.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 53.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
FIGURE 54.ELIXIR MEDICAL CORPORATION.: NET SALES ,($MILLION)
FIGURE 55.MEDTRONIC PLC..: NET SALES ,($MILLION)
FIGURE 56.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 57.BIOSENSORS INTERNATIONAL GROUP.: NET SALES ,($MILLION)
FIGURE 58.TERUMO CORPORATION.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global coronary stents market was valued at $8,814.9 million in 2020 and is projected to reach $15,421.06 million by 2030, registering a CAGR of 6.0% from 2021 to 2030.
Coronary stent is a small expandable tube, which is used for the treatment of narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated using these stents. These stents are also known as cardiac stents and comprise metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI).
The factor that drives growth of coronary stents market include increase in incidence of CAD, rise in innovation in coronary stents, and surge in improved clinical outcomes, due to stenting.
In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity and improved insurance & reimbursement scenario supplement the global coronary stents market growth.
Conversely, availability of alternative methods for coronary heart disease treatment and high cost of treatment associated with coronary stents hinder the growth of the market during forecast years. However, increase in adoption of coronary stents in developing countries is expected to offer lucrative growth opportunities for the market during the forecast period.
The global coronary stents market is segmented on the basis of product, biomaterial, end user, and region. Depending on product, it is classified into drug-eluting stent, bare-metal stent, and bioabsorbable vascular stent. On the basis of biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. According to end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Becton Dickinson and Company, Microport Scientific Corporation, Terumo Corporation, Medtronic plc., Biotronik SE & Co. KG, Biosensors International Group, Ltd., and Elixir Medical Corporation.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（二次医療）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（surgical）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（二次医療）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（surgical）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?